Cytovale

Sep 07, 2025

New Data Reveals Path to SEP-1 Success Includes Early Sepsis Risk Stratification

Apr 22, 2025

ICU-Level Care Not Definitive Indicator for Sepsis, New Study Shows

Mar 18, 2025

Cytovale Names Rhonda Collins Chief Nursing Officer

Feb 04, 2025

Cytovale Names Dave Vort Chief Commercial Officer

Jan 09, 2025

Accelerated Demand for Cytovale's FDA-Cleared Sepsis Detection Solution, IntelliSep®, to Drive Growth in 2025

Dec 09, 2024

Cytovale Recognized as One of Modern Healthcare's 2024 Best in Business

Dec 04, 2024

Hospital Brings Life-Saving Sepsis Detection Technology to Rural Louisiana

Oct 30, 2024

Cytovale's Sepsis Solution Now Available Across Franciscan Missionaries of Our Lady Health System in Louisiana and Mississippi

May 02, 2024

Cytovale's Diagnostic Test Demonstrates Strong Performance in Rapid Identification of Sepsis Risk, Peer-Review Study Confirms

Mar 19, 2024

Cytovale's Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application

Mar 04, 2024

Christopher Slachta Joins Cytovale as Chief Operating Officer